Table: Shin Nippon Biomedical -2025/26 group results

Shin Nippon Biomedical Laboratories

11/05/2026 01:00

May 11 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           32.52           32.41          38.00         16.60    
               (+0.3 pct)      (+22.5 pct)    (+16.8 pct)   (+12.4 pct) 
  Operating        2.65            2.99           3.00        463 mln   
               (-11.1 pct)     (-28.3 pct)    (+13.0 pct)  (+838.9 pct) 
  Recurring        5.83            6.45           6.00          1.95    
               (-9.6 pct)      (-8.1 pct)     (+2.9 pct)    (+19.7 pct) 
  Net
  Net              4.57            4.92           3.50          1.17    
               (-7.3 pct)      (-11.0 pct)    (-23.4 pct)   (+10.0 pct) 
  EPS          109.69 yen      118.29 yen      84.07 yen     28.03 yen  
  Ann Div       50.00 yen       50.00 yen      50.00 yen                
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen                
  -Q4 Div       30.00 yen       30.00 yen      30.00 yen                
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T